Grapevine (Vitis vinifera) products, grape and grape juice, represent a valuable source of bioactive phytochemicals, synthesized by three secondary metabolic pathways (phenylpropanoid, isoprenoid and alkaloid biosynthetic routes) and stored in different plant tissues. In the last decades, compelling evidence suggested that regular consumption of these products may contribute to reducing the incidence of chronic illnesses, such as cancer, cardiovascular diseases, ischemic stroke, neurodegenerative disorders and aging, in a context of the Mediterranean dietary tradition. The health benefits arising from grape product intake can be ascribed to the potpourri of biologically active chemicals occurring in grapes. Among them, the recently discovered presence of melatonin adds a new element to the already complex grape chemistry. Melatonin, and its possible synergistic action with the great variety of polyphenols, contributes to further explaining the observed health benefits associated with regular grape product consumption.
TrichopoulouA, LagiouP, KuperH, TrichopoulosD. (2000) Cancer and Mediterranean dietary traditions. Cancer Epidemiology Biomarkers and Prevention, 9, 869–873.
2.
SimopoulosAP. (2001) The Mediterranean diets: what is so special about the diet of Greece? The scientific evidence. Journal of Nutrition, 131, S3065–3073.
3.
VisioliF, GrandeS, BoganiP, GalliC. (2004) The role of antioxidants in the Mediterranean diets: focus on cancer. European Journal of Cancer Prevention, 13, 337–343.
4.
La VecchiaC, BosettiC. (2007) Diet and cancer risk in Mediterranean countries. Hungarian Medical Journal, 1, 13–23.
5.
HaslerCM. (2000) The changing face of functional foods. Journal of the American College of Nutrition, 19, 499S–506S.
6.
MilnerJA. (2000) Functional foods: the US perspective. American Journal of Clinical Nutrition, 71, 1654S–1659S.
7.
HeberD. (2004) Phytochemicals beyond antioxidation. Journal of Nutrition, 134, 3175S–3176.
8.
ZhaoJ. (2007) Nutraceuticals, nutritional therapy, phytonutrients and phytotherapy for improvement of human health: a perspective on plant biotechnology application. Recent Patens in Biotechnology, 1, 75–97.
9.
MikešO, VrchotováN, TřískaJ, KyselákováM, ŠmidrkalJ. (2008) Distribution of major polyphenolic compounds in vine grapes of different cultivars growing in south Moravian vineyards. Czech Journal of Food Science, 26, 182–189.
10.
IritiM, FaoroF. (2006) Grape phytochemicals: a bouquet of old and new nutraceuticals for human health. Medical Hypothesis, 67, 833–838.
11.
PezzutoJM. (2008) Grapes and human health: a perspective. Journal of Agricultural and Food Chemistry, 56, 6777–6784.
12.
JeandetP, Douillet-BreuilA-C, BessisR, DebordS, SbaghiM, AdrianM. (2002) Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity and metabolism. Journal of Agricultural and Food Chemistry, 50, 2731–2741.
13.
IritiM, FaoroF. (2004) Plant defense and human nutrition: the phenylpropanoids on the menù. Current Topics in Nutraceuticals Research, 2, 47–65.
14.
GabriacB, Werck-ReichhartD, TeutschH, DurstF. (1991) Purification and immunocharacterization of a plant cytochrome P450: the cinnamic acid 4-hydroxylase. Archives of Biochemistry and Biophysics, 288, 302–309.
15.
YeZ, ZhongR, MorrisonWHIII, HimmelsbachDS. (2001) Caffeoyl coenzyme A O-methyltransferase and lignin biosynthesis. Phytochemistry, 57, 1177–1185.
16.
HerrmannK. (1989) Occurrence and content of hydroxycinnamic acid and hydroxybenzoic acid compounds in foods. Critical Review in Food Science and Nutrition, 28, 315–347.
17.
MurphyJB, StutteCA. (1978) Analysis for substituted benzoic and cinnamic acids using high pressure liquid chromatography. Analytic Biochemistry, 86, 220–228.
18.
IwashinaT. (2000) The structure and distribution of the flavonoids in plants. Journal of Plant Research, 113, 287–299.
19.
MazzaG. (1995) Anthocyanins in grapes and grape products. Critical Review Food Science Nutritional, 35, 341–371.
20.
CliffordMN. (2000) Anthocyanins – nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture, 80, 1063–1072.
21.
LangcakeP. (1981) Disease resistance of Vitis spp. and the production of stress metabolites resveratrol, ∊-viniferin, α-viniferin and pterostilbene. Physiological Plant Pathology, 18, 213–226.
22.
WaterhouseAL, Lamuela-RaventosRM. (1994) The occurrence of piceid, a stilbene glucoside, in grape berries. Phytochemistry, 37, 571–573
JeandetP, BessisR, GautheronB. (1991) The production of resveratrol (3,5,4′-trihydroxystilbene) by grape berries in different developmental stages. American Journal of Enology and Viticulture, 42, 41–46.
25.
JeandetP, SbaghiM, BessisR, MeunierP. (1995) The potential relationship of stilbene (resveratrol) synthesis to anthocyanin content in grape berry skins. Vitis, 34, 91–94.
26.
IritiM, RossoniM, BorgoM, FaoroF. (2004) Benzothiadiazole enhances resveratrol and anthocyanin biosynthesis in grapevine, meanwhile improving resistance to Botrytis cinerea. Journal of Agricultural and Food Chemistry, 52, 4406–4413.
27.
Santos-BuelgaC, ScalbertA. (2000) Proanthocyanidins and tannin-like compounds - nature, occurrence, dietary intake and effects on nutrition and health. Journal of the Science of Food and Agriculture, 80, 226–230.
28.
PieurC, RigaudJ, CheynierV, MoutounetM. (1994) Oligomeric and polymeric procyanidins from grape seed. Phytochemistry, 36, 781–784.
GabettaB, FuzzatiN, GriffiniA, LollaE, PaceR, RuffilliT, PeterlongoF. (2000) Characterization of proanthocyanidins from grape seeds. Fitoterapia, 71, 162–175.
31.
PisarnitskiiAF. (2001) Formation of wine aroma: tones and imperfections caused by minor components. Applied Biochemistry and Microbiology, 37, 552–560.
32.
Sejer PedersenD, CaponeDL, SkouroumounisGK, PollnitzAP, SeftonMA. (2003) Quantitative analysis of geraniol, nerol, linalool and α-terpineol in wine. Analytical and Bioanalytical Chemistry, 375, 517–522.
33.
HolsteinSA, HohlRJ. (2004) Isoprenoids: remarkable diversity of form and function. Lipids, 34, 293–309.
34.
IritiM, FaoroF. (2006) Lipids Biosynthesis in Spermatophyta. In Floriculture, Ornamental and Plant Biotechnology: Advances and Topical Issues.1, Teixeira da SilvaJA. (Ed). Global Science Books, London UK. 359–372.
35.
DuncanRE, LauD, El-SohemyA, ArcherMC. (2004) Geraniol and β-ionone inhibit proliferation, cell cycle progression and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochemical Pharmacology, 68, 1739–1747.
36.
KotseridisY, BaumesRL, BertrandA, SkouroumounisGK. (1999) Quantitative determination of β-ionone in red wines and grapes of Bordeaux using a stable isotope dilution assay. Journal of Chromatography A, 848, 317–325.
37.
KotseridisY, BaumesRL, SkouroumounisGK. (1999) Quantitative determination of free and hydrolytically liberated β-damascenone in red grapes and wines using a stable isotope dilution assay. Journal of Chromatography A, 849, 245–254.
38.
BaumesR, WirthJ, BureauS, GunataY, RazunglesA. (2002) Biogeneration of C13-norisoprenoid compounds: experiment supportive for an apo-carotenoid pathway in grapevines. Analytica Chimica Acta, 458, 3–14.
39.
PineauB, BarbeJ-C, Van LeeuwenC, DubourdieuD. (2007) Which impact for β-damascenone on red wine aroma?Journal of Agricultural and Food Chemistry, 55, 4103–4108.
40.
LiuJ-R, SunX-R, DongH-W, SunC-H, SunW-G, ChenB-Q, SongY-Q, YangB-F. (2008) β-ionone suppresses mammary carcinogenesis, proliferative activity and induces apoptosis in the mammary gland of the Sprague-Dawley rat. International Journal of Cancer, 122, 2689–2698.
41.
MoH, ElsonCE. (1999) Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. Journal of Nutrition, 129, 804–813.
42.
LiuJ-R, YangB-F, ChenB-Q, YangY-M, DongH-W, SongY-Q. (2004) Inhibition of β-ionone on SGC-7901 cell proliferation and upregulation of metalloproteinase-1 and -2 expression. World Journal of Gastroenterology, 10, 167–171.
43.
LiuJ-R, ChenB-Q, YangB-F, DongH-W, SunC-H, WangQ, SongG, SongY-Q. (2004) Apoptosis of human gastric adenocarcinoma cells induced by β-ionone. World Journal of Gastroenterology, 10, 348–351.
44.
JanakiramNB, CoomaI, MohammedA, SteeleVE, RaoCV. (2008) β-Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth and induces retinoid X receptor-α in human colon cancer cells. Molecular Cancer Therapy, 7, 181–190.
45.
CoelhoE, RochaSM, DelgadilloI, CoimbraMA. (2006) Headspace-SPME applied to varietal volatile components evolution during Vitis vinifera L. cv. ‘Braga’ ripening. Analytica Chimica Acta, 563, 204–214.
TasinM, AnforaG, IoriattiC, CarlinS, De CristoforoA, SchmidtS, BengtssonM, VersiniG, WitzgallP. (2004) Antennal and behavioural response of Lobelia botrana to volatiles from grapevine. Journal of Chemical Ecology, 31, 77–87.
48.
HerraizT. (1999) 1-Methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxilic acid and 1,2,3,4-tetrahydro-β-carboline-3-carboxilic acid in fruits. Journal of Agricultural and Food Chemistry, 47, 4883–4887.
49.
HerraizT, GalisteoJ. (2002) Tetrahydro-β-carboline alkaloids that occur in foods and biological systems act as radical scavengers and antioxidants in the ABTS assay. Free Radical Research, 36, 923–928.
50.
HerraizT, GalisteoJ. (2003) Tetrahydro-β-carboline alkaloids occur in fruits and fruit juice. Activity as antioxidant and radical scavengers. Journal of Agricultural and Food Chemistry, 51, 7156–7161.
51.
HerraizT. (2007) Identification and occurrence of β-carboline alkaloids in raisins and inhibition of monoamine oxidase (MAO). Journal of Agricultural and Food Chemistry, 55, 8534–8540.
52.
BrossiA, FocellaA, TeitelS. (1973) Alkaloids in mammalian tissues. 3. Condensation of L-tryptophan and L-5-hydroxytryptophan with formaldehyde and acetaldehyde. Journal of Medicinal Chemistry, 16, 418–420.
53.
BuckholtzNS. (1980) Neurobiology of tetrahydro-β-carbolines. Life Sciences, 27, 893–903.
54.
AiraksinenMM, KariI. (1981) β-Carbolines, psychoactive compounds in the mammalian body. 1. occurrence, origin and metabolism. Medicine and Biology, 59, 21–34.
55.
YamadaM, YasuharaH. (2004) Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology, 25, 215–221.
56.
YoudimMBH, EdmondsonD, TiptonKF. (2006) The therapeutic potential of monoamine oxidase inhibitors. Nature Reviews in Neuroscience, 22, 197–217.
57.
PariK, SundariCS, ChandaniS, BalasubramanianD. (2000) β-Carbolines that accumulate in human tissues may serve a protective role against oxidative stress. Journal of Biological Chemistry, 275, 2455–2462.
58.
ChenQ, ChaoR, ChenH, HouX, YanH, ZhouS, PengW, XuA. (2004) Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. International Journal of Cancer, 114, 675–682.
59.
HerraizT. (1996) Occurrence of tetrahydro-β-carboline-3-carboxylic acids in commercial foodstuffs. Journal of Agricultural and Food Chemistry, 44, 3057–3065.
60.
GonzalesGF, Gonzales-CastañedaC. (2008) The methyltetrahydro-β-carbolines in Maca (Lepidium meyenii). Evidence-based Complementary and Alternative Medicine, doi: 10.1093/ecam/nen041.
61.
IritiM, RossoniM, FaoroF. (2006). Melatonin content in grape: myth or panacea?Journal of the Science of Food and Agriculture, 86, 1432–1438.
62.
IritiM. (2008) Melatonin in grape, not just a myth, maybe a panacea. Journal of Pineal Research, doi: 10.1111/j.1600-079X.2008.00616.x
KolářJ, MacháčkováI. (2005) Melatonin in higher plants: occurrence and possible functions. Journal of Pineal Research, 39, 333–341
65.
Hernández-RuizJ, CanoA, ArnaoMB. (2005) Melatonin acts as a growth-stimulating compound in some monocot species. Journal of Pineal Research, 39, 137–142.
66.
ArnaoMB, Hernández-RuizJ. (2007) Melatonin promotes adventitious- and lateral root regeneration in etiolated hypocotyls of Lupinus albus L. Journal of Pineal Research, 42, 147–152.
67.
AxelrodJ, WeissbachH. (1961) Purification and properties of hydroxyindole-O-methyltransferase. Journal of Biological Chemistry, 236, 211–213.
68.
MarcoliniL, SaracinoMA, BugamelliF (2008) HPLC-F analysis of melatonin and resveratrol isomers in wine using a SPE procedure. Journal of Separation Science, 31, 1007–1014.
69.
GuerreroJM, Martínez-CruzF, ElorzaFL. (2008) Significant amount of melatonin in red wine: its consumption increases blood melatonin levels in humans. Food Chemistry, doi: 10.1016/j.foodchem.2008.02.007.
70.
ReiterRJ, TanD-X, Pilar TerronM, FloresLJ, CzarnockiZ. (2007) Melatonin and its metabolites: new findings regarding their production and their radical scavenging action. Acta Biochimica Polonica, 54, 1–9.
71.
PiettaP-G. (2000) Flavonoids as antioxidants. Journal of Natural Products, 63, 1035–1042.
72.
AmesBN, ShigenagaMK, HagenTM. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences USA, 90, 7915–22.
73.
HalliwellB. (1997) Antioxidants and human disease: a general introduction. Nutrition Reviews, 55, S44–S49.
74.
DahlgrenC, KarlssonA. (1999) Respiratory burst in human neutrophils. Journal of Immunological Methods, 232, 3–14.
75.
LeeJ, KooN, MinDB. (2004) Reactive oxygen species, aging, and antioxidant nutraceuticals. Comprhensive Reviews in Food Science and Food Safety, 3, 21–33.
76.
WisemanH. (1996) Dietary influences on membrane function: importance in protection against oxidative damage and disease. Journal of Nutritional Biochemistry, 7, 2–15.
YuBP. (1994) Cellular defenses against damage from reactive oxygen species. Physiological Reviews, 74, 139–162.
79.
CaoG, SoficE, PriorRL. (1997) Antioxidant and prooxidant behavior of flavonoids: structure–activity relationships. Free Radical Biology and Medicine, 22, 749–760.
80.
PriorRL, CaoG. (2000) Antioxidant phytochemicals in fruits and vegetables: diet and health implications. Horticulture Science, 35, 588–592.
81.
VinsonJA, YangJH, ProchJ, LiangX. (2000) Grape juice, but not orange juice, has in vitro, ex vivo and in vivo antioxidant properties. Journal of Medicinal Food, 2, 167–171.
82.
VinsonJA, TeufelK, WuN. (2001) Red wine, dealcoholized red wine and specially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis, 156, 67–42.
83.
BorsW, HellerW, MichelC, SaranM. (1990) Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods in Enzymology, 186, 343–355.
FrankelEN. (1999) Food antioxidants and phytochemicals: present and future perspectives. Fett/Lipid, 101, 450–455.
86.
WangH, CaoG, PriorRL. (1996) Total antioxidant capacity of fruits. Journal of Agricultural and Food Chemistry, 44, 701–705.
87.
WolfeKL, KangX, HeX, DongM, ZhangQ, LiuRH. (2008) Callular antioxidant activity of common fruits. Journal of Agricultural and Food Chemistry, 56, 8418–8426.
88.
O'ByrneDJ, DevarajS, GrundySM, JialalI. (2002) Comparison of the antioxidant effects of Concord grape juice flavonoids and α-tocopherol on markers of oxidative stress in healthy adults. American Journal of Clinical Nutrition, 76, 1367–1374.
89.
DayAP, KempHJ, BoltonC, HartogM, StansbieD. (1997) Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation. Annals of Nutrition & Metabolims, 41, 353–357.
90.
García-AlonsoJ, RosG, Vidal-GuevaraML, PeriagoMJ. (2006) Acute intake of phenolic-rich juice improves antioxidant status in healthy subjects. Nutrition Research, 26, 330–339.
91.
ZernTL, WoodRJ, GreeneC, WestKL, LiuY, AggarwalD, ShachterNS, FernándezML. (2005) Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. Journal of Nutrition, 135, 1911–1917.
ParkYK, ParkE, KimJ-S, KangM-H. (2003) Daily grape juice consumption reduces oxidative DNA damage and plasma free radical levels in healthy Koreans. Mutation Research, 529, 77–86.
94.
StankovićM, TeševićV, VajsV, TodorovićN, MilosavljevićS, GođevacD. (2008) Antioxidant properties of grape seed extract on human lymphocyte oxidative defence. Planta Medica, 74, 730–735.
95.
StagosD, KazantzoglouG, TheofanidouD, KakalopoulouG, MagiatisP, MitakuS, KouretasD. (2006) Activity of grape extracts from Greek varieties of Vitis vinifera against mutagenicity induced by bleomycin and hydrogen peroxide in Salmonella typhimurium strain TA102. Mutation Research, 609, 165–175
96.
ChengKC, CahillDS, KasaiH, NishimuraS, LoebLA. (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. Journal of Biological Chemistry, 267, 166–172.
97.
SgambatoA, ArditoR, FaragliaB, BoninsegnaA, WolfFI, CittadiniA. (2001) Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutation Research, 496, 171–180.
98.
De SalviaR, FestaF, RicordyR, ParticoneP, CozziR. (2002) Resveratrol affects in a different way primary versus fixed DNA damage induced by H2O2 in mammalian cells in vitro. Toxicology Letters, 135, 1–9.
da LuzPL, CoimbraSR. (2004) Wine, alcohol and atherosclerosis: clinical evidences and mechanisms. Brazilian Journal of Medical and Biological Research, 37, 1275–1295.
101.
SteinJH, KeevilJG, WiebeDA, AeschlimannS, FoltsJD. (1999) Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation, 100, 1050–1055.
102.
ChouEJ, KeevilJG, AeschlimannS, WiebeDA, FoltsJD, SteinJH. (2001) Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. American Journal of Cardiology, 88, 553–555.
103.
CoimbraSR, LageSH, BrandizziL, YoshidaV, da LuzPL. (2005) The action of red wine and purple grape juice on vascular reactivity is independent of plasma lipids in hypercholesterolemic patients. Brazilian Journal of Medical and Biological Research, 38, 1339–1347.
104.
LekakisJ, RallidisLS, AndreadouI, VamvakouG, KazantzoglouG, MagiatisP, SkaltsounisA-L, KremastinosD. (2005) Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. European Journal of Cardiovascular Prevention and Rehabilitation, 12, 596–600.
105.
DemrowHS, SlanePR, FoltsJD. (1995) Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation, 91, 1182–1188.
106.
FreedmanJE, ParkerC, LiL, PerlmanJA, FreiB, IvanovV, DeakLR, IafratiMD, FoltsJD. (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation, 103, 2792–2798.
107.
FreedmanJE, LoscalzoJ, BarnardMR, AlpertC, KeaneyJF, MichelsonAD. (1997) Nitric oxide released from activated platelets inhibits platelet recruitment. Journal of Clinical Investigation, 100, 350–356.
108.
KeevilJG, OsmanHE, ReedJD, FoltsJD. (2000) Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. Journal of Nutrition, 130, 53–56.
109.
ShanmuganayagamD, BeahmMR, OsmanHE,. KruegerGG, ReedJD, FoltsJD. (2002) Grape seed and grape skin extracts elicit a greater antiplatelet effect when used in combination than when used individually in dogs and humans. Journal of Nutrition, 132, 3592–3598.
110.
CastillaP, EcharriR, DávalosA, CerratoF, OrtegaH, TeruelJL, LucasMF, Gómez-CoronadoD, OrtuñoJ, LasunciónMA. (2006) Concentrated red grape juice exerts antioxidant, hypolipidemic, and anti-inflammatory effects in both hemodialysis patients and healthy subjects. American Journal of Clinical Nutrition, 84, 252–862.
111.
ParkYK, KimJ-S, KangM-H. (2004) Concorde grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. BioFactors, 22, 145–147.
112.
CorderR, DouthwaiteJA, LeesDM, KhanNQ, Viseu Dos SantosAC, WoodEG, CarrierMJ. (2001) Endothelin-1 synthesis reduced by red wine. Nature, 414, 863–864.
113.
FumagalliF, RossoniM, IritiM, Di GennaroA, FaoroF, BorroniE, BorgoM, ScienzaA, SalaA, FolcoG. (2006) From field to health: a simple way to increase the nutraceutical content of grape as shown by NO-dependent vascular relaxation. Journal of Agricultural and Food Chemistry, 54, 5344–5349.
114.
MartinS, GiannoneG, AndriantsitohainaR, MartinezMC. (2003) Delphinidin, an active compound of red wine, inhibits endothelial cell apoptosis via nitric oxide pathway and regulation of calcium homeostasis. British Journal of Pharmacology, 139, 1095–1102.
115.
BrandK, PageS, WalliAK, NeumeierD, BauerlePA. (1997) Role of nuclear factor NF-kB in atherogenesis. Experimental Physiology, 82, 297–304.
116.
CsiszarA, SmithK, LabinskyyN, OroszZ, RiveraA, UngvariZ. (2006) Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. American Journal of Physiology: Heart and Circulation Physiology, 291, H1694–H1699.
117.
DelmasD, JanninB, LatruffeN. (2005) Resveratrol, preventing properties against vascular alterations and ageing. Molecular Nutrition and Food Science, 49, 377–395.
118.
Perez-VizcainoF, DuarteJ, AndriantsitohainaR. (2006) Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radical Research, 40, 1054–1065.
119.
DuarteJ, Perez-VizcainoF, ZarzueloA, JimenezJ, TamargoJ. (1993) Vasodilator effects of quercetin on isolated rat vascular smooth muscle. European Journal of Pharmacology, 239, 1–7.
120.
Perez-VizcainoF, IbarraM, CogolludoAL, DuarteJ, Zaragoza-ArnaezF, MorenoL, Lopez-LopezJ, TamargoJ. (2002) Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. Journal of Pharmacology and Experimental Therapy, 302, 66–72.
121.
DuarteJ, Perez-PalenciaR, VargasF, OceteMA, Perez-VizcainoF, ZarzueloA, TamargoJ. (2001) Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. British Journal of Pharmacology, 133, 117–124.
122.
DuarteJ, JimenezR, O'ValleF, GalisteoM, Perez-PalenciaR, VargasF, Perez-VizcainoF, ZarzueloA, TamargoJ. (2002) Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. Journal of Hypertension, 20, 1843–1854.
123.
GalisteoM, Garcia-SauraMF, JimenezR, VillarIC, WangensteenR, ZarzueloA, VargasF, DuarteJ. (2004) Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Planta Medica, 70, 334–341.
124.
SanchezM, GalisteoM, VeraR, VillarIC, ZarzueloA, TamargoJ, Perez-VizcainoF, DuarteJ. (2006) Quercetin down-regulates NADPH oxidase, increses eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. Journal of Hypertension, 24, 75–84.
125.
WattenbergLW. (1985) Chemoprevention of cancer. Cancer Research, 45, 1–8.
126.
GreewaldP. (2002) Cancer chemoprevention. British Medical Journal, 324, 714–718.
127.
YoungG, Le LeuR. (2002) Preventing cancer: dietary lifestyle or clinical intervention?. Asian Pacific Journal of Clinical Nutrition, 11, S618–S631.
128.
SuhrY-J. (2003) Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer, 3, 768–780.
129.
GargAK, BuchholzTA, AggarwalBB. (2005) Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxidants and Redox Signalling, 7, 1630–1647.
130.
FrescoP, BorgesF, DinizC, MarquesMPM. (2006) New insights on the anticancer properties of dietary polyphenols. Medical Research Reviews, 26, 747–766.
131.
HailN, CortesM, DrakeEN, SpallholzJE. (2008) Cancer chemoprevention: A radical perspective. Free Radical Biology and Medicine, 45, 97–110.
132.
JangM, CaiL, UdeaniGO, SlowingKV, ThomasCF, BeecherCW, FongHH, FarnsworthNR, KinghornAD, MehtaRG, MoonRC, PezzutoJM. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218–220.
133.
Holmes-McNaryM, BaldwinAS. (2000) Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Research, 60, 3477–3483.
134.
MannaSK, MukhopadhyayA, AggarwalBB. (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. Journal of Immunology, 164, 6509–6519.
135.
DongZ. (2003) Molecular mechanism of the chemopreventive effect of resveratrol. Mutation Research, 523-524, 145–150.
136.
PervaizS. (2003) Resveratrol: from grapevines to mammalian biology. FASEB Journal, 17, 1975–1985.
137.
HouD-X, KaiK, LiJJ, LinS, TeraharaN, WakamatsuM, FujiiM, YoungMR, ColburnN. (2004) Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms. Carcinogenesis, 25, 29–36.
138.
BaurJA, PearsonKJ, PriceNL, JamiesonHA, LerinC, KalraA, PrabhuVV, AllardJS, Lopez-LluchG, LewisK, PistellPJ, PoosalaS, BeckerKG, BossO, GwinnD, WangM, RamaswamyS, FishbeinKW, SpencerRG, LakattaEG, Le CouteurD, ShawRJ, NavasP, PuigserverP, IngramDK, de CaboR, SinclairDA. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337–342.
139.
AtharM, BackJH, TangX, KimKH, KopelovichL, BickersDR, KimAL. (2007) Resveratrol: a review of preclinical studies for human cancer prevention. Toxicology and Applied Pharmacology, 224, 274–283
140.
MitchellSH, ZhuW, YoungCY. (1999) Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Research, 59, 5892–5895.
141.
XingN, ChenY, MitchellSH, YoungCY. (2001) Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis, 22, 409–414.
142.
HsiehTC, WuJM. (1999) Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Experimental Cell Research, 249, 109–115.
143.
LuR, SerreroG. (1999) Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. Journal of Cellular Physiology, 179, 297–304.
144.
BaslyP, Marre-FournierF, Le BailJC, HabriouxG, ChuliaAJ. (2000) Estrogenic/antiestrogenic and scavenging properties of (E)-and (Z)-resveratrol. Life Science, 66, 769–777.
145.
BhatKP, LantvitD, ChristovK, MehtaRG, MoonRC, PezzutoJM. (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Research, 61, 7456–7463.
146.
OsoskiAL, KennellyEJ. (2003) Phytoestrogens: a review of the present state of research. Phytotherapy Research, 17, 845–869.
147.
KijimaI, PhungS, HurG, KwokSL, ChenS. (2006) Grape seed extract is an aromatase inhibitor and a supressor of aromatase expression. Cancer Research, 66, 5960–5967.
148.
SunXZ, ZhouD, ChenS. (1997) Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells. Journal of Steroid Biochemistry and Molecular Biology, 63, 29–36.
149.
CiolinoHP, YehGC. (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Molecular Pharmacology, 56, 760–767.
150.
ChanWK, DelucchiAB. (2000) Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4. Life Science, 67, 3103–3112.
151.
ChangTK, ChenJ, LeeWB. (2001) Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. Journal of Pharmacology and Experimental Therapy, 299, 874–882.
152.
ClementMV, PontonA, PervaizS. (1998) Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Letters, 440, 13–18.
153.
HuangC, MaW, GoransonA, DongZ. (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis, 20, 237–242.
154.
SuhrYJ, HurhYJ, KangYJ, LeeE, KongG, LeeSJ. (1999) Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cell. Cancer Letters, 140, 1–10.
155.
DorrieJ, GerauerH, WachterY, ZuninoSJ. (2001) Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Research, 61, 4731–4739.
156.
TinhoferI, BernhardD, SenfterM, AnetherG, LoefflerM, KroemerG, KoflerR, CsordasA, GreilR. (2001). Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB Journal, 15, 1613–1615.
157.
RomanV, BillardC, KernC, Ferry-DumazetH, IzardJC, MohammadR, MossalayiDM, KolbJP. (2002) Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. British Journal of Haematology, 117, 842–851.
158.
SoleasGJ, GoldbergDM, GrassL, LevesqueM, DiamandisEP. (2001) Do wine polyphenols modulate p53 gene expression in human cancer cell lines?Clinical Biochemistry, 34, 415–420.
159.
SchneiderY, FischerB, CoelhoD, RoussiS, GosseF, BischoffP, RaulF. (2004) (Z)-3,5,4′-Tri-O-methyl-resveratrol, induces apoptosis in human lymphoblastoid cells independently of their p53 status. Cancer Letters, 211, 155–161.
160.
FontecaveM, LepoivreM, ElleingandE, GerezC, GuittetO. (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Letters, 421, 277–279.
161.
RagioneFD, CucciollaV, BorrielloA, PietraVD, RacioppiL, SoldatiG, MannaC, GallettiP, ZappiaV. (1998) Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochemical and Biophysical Research Communications, 250, 53–58.
162.
HsiehTC, BurfeindP, LaudK, BackerJM, TraganosF, DarzynkiewiczZ, WuJM. (1999) Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. International Journal of Oncology, 15, 245–252.
163.
BernhardD, TinhoferI, TonkoM, HublH, AusserlechnerMJ, GreilR, KoflerR, CsordasA. (2000) Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death and Differentiation, 7, 834–842.
164.
JoeAK, LiuH, SuzuiM, VuralME, XiaoD, WeinsteinIB. (2002) Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clinical Cancer Research, 8, 893–903.
165.
SchneiderY, VincentF, DurantonB, BadoloL, GosseF, BergmannC, SeilerN, RaulF. (2000) Antiproliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Letters, 158, 85–91.
166.
TsanF, WhiteJE, MaheshwariJG, ChikkappaG. (2002) Antileukemia effect of resveratrol. Leukaemia and Lymphoma, 43, 983–987.
167.
AgarwalC, SharmaY, ZhaoJ, AgarwalR. (2000) A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation. Clinical Cancer Research, 6, 2921–2930.
168.
SinghRP, TyagiAK, DhanalakshmiS, AgarwalR, AgarwalC. (2004) Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3. International Journal of Cancer, 108, 733–740.
169.
MantenaSK, BaligaMS, KatiyarSK. (2006) Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis, 27, 1682–1691.
170.
JohnsonIT. (2002) Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. Food Chemistry and Toxicology, 40, 1171–1178.
171.
Durakİ, ÇetinR, DevrimE, ErgüderİB. (2005) Effects of black grape extract on activities of DNA turnover enzymes in cancerous and non cancerous human colon tissues. Life Sciences, 76, 2995–3000.
172.
Durakİ, BiriH, ErgüderİB, DevrimE, ŞenocakÇ, AvcıA. (2007) Effects of garlic and black grape extracts on the activity of adenosine deaminase from cancerous and noncancerous human urinary bladder tissues. Medicinal Chemistry Research, 16, 259–265.
173.
KaurM, SinghRP, GuM, AgarwalR, AgarwalC. (2006) Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells. Clinical Cancer Research, 12, 6194–6202.
174.
López-OlivaME, Agis-TorresA, García-PalenciaP, GoñiI, Muñoz-MartínezE. (2006) Induction of epithelial hypoplasia in rat cecal and distal colonic mucosa by grape antioxidant dietary fiber. Nutrition Research, 26, 651–658.
175.
BirtDF, MitchellD, GoldB, PourP, PinchHC. (1997) Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Research, 17, 85–91.
176.
AdhamiVM., AfaqF, AhmadN. (2003) Suppression of ultraviolet B exposure-mediated activation of NF-κB in normal human keratinocytes by resveratrol. Neoplasia, 5, 74–82.
177.
MittalA, ElmetsCA, KatiyarSK. (2003) Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis, 24, 1379–1388.
178.
SharmaSD, MeeranSM, KatiyarSK. (2007) Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-kB signaling in in vivo SKH-1 hairless mice. Molecular Cancer Therapeutics, 6, 995–1005.
179.
NilesRM, McFarlandM, WeimerMB, RedkarA, FuY-M, MeadowsG.G. (2003) Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Letters, 190, 157–163.
180.
JemalA, SiegelR, WardE, HaoY, XuJ, MurrayT, ThunMJ. (2008) Cancer statistics, 2008. CA Cancer Journal of Clinical, 58, 71–96.
181.
WangZ, DesmoulinS, BanerjeeD, LiY, DeraniyagalaRL, AbbruzzeseJ, SarkarFH. (2008) Synegistic effects of multiple natural products in pancreatic cancer cells. Life Sciences, 83, 293–300.
182.
Jane-SalasE, Chimenos-KustnerE, Lopez-LopezJ, Rosello-LlabresX. (2003) Importance of diet in the prevention of oral cancer. Medicina Oral, 8, 260–268.
183.
DaviesL, WelchHG. (2006) Epidemiology of head and neck cancer in the United States. Otolaryngology, Head and Neck Surgery, 135, 451–457.
184.
PaviaM, PileggiC, NobileCG, AngelilloIF. (2006) Association between fruit and vegetable consumption and oral cancer: a metaanalysis of observational studies. American Journal of Clinical Nutrition, 83, 1126–1134.
185.
KingM, ChatelainK, FarrisD, JensenD, PickupJ, SwappA, O'MalleyS, KingsleyK. (2007) Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer. BMC Complementary and Alternative Medicine 2007, 7:22 doi:10.1186/1472-6882-7-22.
186.
ChatelainK, PhippenS, McCabeJ, TeetersCA, O'MalleyS, KingsleyK. (2008) Cranberry and grape sees extracts inhibit the proliferative phenotype of oral squamous cell carcinomas. Evidence-based Complementary and Alternative Medicine, doi: 10.1093/ecam/nen047.
187.
ReiterR. (1998) Cytoprotective properties of melatonin: presumed association with oxidative damage and aging. Nutrition, 14, 691–696.
188.
AllegraM, ReiterRJ, TanDX, GentileC, TesoriereL, LivreaMA. (2003) The chemistry of melatonin's interaction with reactive species. Journal of Pineal Research, 34, 1–10.
189.
BurkhardtS, ReiterRJ, TanD-X, HardelandR, CabreraJ, KarbownikM. (2001) DNA oxidatively damaged by chromium(III) and H2O2 is protected by melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, resveratrol and uric acid. International Journal of Biochemistry and Cell Biology, 33, 775–783.
190.
MayoJC, SainzRM, TanD-X, HardelandR, LeonJ, RodriguezC, ReiterRJ. (2005) Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. Journal of Neuroimmunology, 165, 139–149.
191.
XimenesVF, FernandesJR, BuenoVB, CatalaniLH, OliveiraGH, MachadoRGP. (2007) The effect of pH on horseradish peroxidase-catalyzed oxidation of melatonin: production of N1-acetyl-N2-formyl-5-methoxykynuramine versus radical-mediated degradation. Journal of Pineal Reserach, 42, 291–296.
López-BurilloS, TanD-X, MayoJC, SainzRM, ManchesterLC, ReiterRJ. (2003) Melatonin, xanthurenic acid, resveratrol, EGCG Vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by fenton reagents: a study of their individual and synergistic actions. Journal of Pineal Research, 34, 269–277.
194.
WeinertBT, TimirasPS. (2003) Theories of aging. Journal of Applied Physiology, 95, 1706–1716.
195.
HakimFT, FlomerfeltFA, BoyiadzisM, GressRE. (2004) Aging, immunity and cancer. Current Opinion in Immunology, 16, 151–156.
196.
OlinskiR, SiomekA, RozalskiR, GackowskiD, FoksinskiM, GuzJ, DziamanT, SzpilaA, TudekB. (2007) Oxidative damage to DNA and antioxidant status in aging and age-related diseases, Acta Biochimica Polonica, 54, 11–26.
197.
AmesBN. (1989) Endogenous oxidative DNA damage, aging, and cancer. Free Radical Research Communications, 7, 121–128.
198.
SrinivasanV, MaestroniGJM, CardinaliDP, EsquifinoAI, Pandi-PerumalSR, MillerSC. (2005) Melatonin, immune function and aging. Immunity & Ageing, 2, 17–23.
199.
Pandi-PerumalSR, SeilsLK, KayumovL, RalphMR, LoweA, MollerH, SwaabDF. (2002) Senescence, sleep, and circadian rhythms. Ageing Research Reviews, 1, 559–604.
200.
MaestroniGJ, ContiA. (1991) Anti-stress role of the melatonin-immuno-opioid network: evidence for a physiological mechanism involving T cell-derived, immunoreactive beta-endorphin and MET-enkephalin binding to thymic. opioid receptors. International Journal of Neuroscience, 61, 289–298.
201.
Carrillo-VicoA, CalvoJR, AbreuP, LardonePJ, Garcia-MaurinoS, ReiterRJ, GuerreroJM. (2004) Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB Journal, 18, 537–539.
202.
McCayCM, CrowellMF, MaynardLA. (1935) The effect of restricted growth upon the length of life and upon the ultimate body size. Journal of Nutrition, 10, 63–79.
203.
LinS-J, DefossezPA, GuarenteL. (2000) Requirment of NAD and Sir2 for lifespan extension by caloric restriction in Saccharomyces cerevisiae. Science, 289, 2126–2128.
204.
MasoroEJ. (2004) Role of sirtuin proteins in life extension by caloric restriction. Mechanisms of Ageing and Development, 125, 591–594.
205.
YamamotoH, SchoonjansK, AuwerxJ. (2007) Sirtuin functions in health and disease. Molecular Endocrinology, 21, 1745–1755.
SinclairDA. (2005) Sirtuins for healthy neurons. Nature Genetic, 37, 339–340.
209.
PorcuM, ChiarugiA. (2005) The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends in Pharmacological Sciences, 26, 94–103.
210.
MaestroniGJ. (2001) The immunotherapeutic potential of melatonin. Expert Opinion in Investigation Drugs, 10, 467–476.
211.
PappollaM, BoznerP, SotoC, ShaoH, RobakisNK, ZagorskiM, FrangioneB, GhisoJ. (1998) Inhibition of Alzheimer beta-fibrillogenesis by melatonin. Journal of Biological Chemistry, 273, 7185–7188.
212.
PappollaMA, ChyanY, PoeggelerB, FrangioneB, WilsonG, GhisoJ, ReiterRJ. (2000) An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: Implications for Alzheimer's disease. Journal of Neural Transmission, 107, 203–231.
213.
MarambaudP, ZhaoH, DaviesP. (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-ß peptides. Journal of Biological Chemistry, 280, 37377–37382.
214.
PoratY, AbramowitzA, GazitE. (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chemical Biologu and Drug Design, 67, 27–37.
215.
WangJ, HoL, ZhaoW, OnoK, RosensweigC, ChenL, HumalaN, TeplowDB, PasinettiGM. (2008) Grape-derived polyphenolics prevent A β oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. Journal of Neuroscience, 28, 6388–6392.
216.
Acuña-CastroviejoD, Coto-MontesA, Gaia MontiM, OrtizGG, ReiterRJ. (1997) Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sciences, 60, PL23–PL29.
217.
OrtizGG, Crespo-LópezME, Moran-MoguelC, GarciaJJ, ReiterRJ, Acuña-CastroviejoD. (2001) Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo. Neuroendocrinology Letters, 22, 101–108.
218.
AntolinI, MayoJC, SainzRM, del BrioML, HerreraF, MartinV, RodriquezC. (2002) Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Research, 943, 163–173.
219.
ManachC, ScalbertA, MorandC, RémésyC, JimenezL, (2004) Polyphenols – food sources and bioavailability. American Journal of Clinical Nutrition, 79, 727–747.
220.
ManachC, WilliamsonG, MorandC, ScalbertA, RemesyC. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies American Journal of Clinical Nutrition, 81, 230S–242S.
221.
WilliamsonG, ManachC. (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. American Journal of Clinical Nutrition, 81, 243S–255S.
222.
WilkinsonAP, WähäläK, WilliamsonG. (2002) Identification and quantification of polyphenol phytoestrogens in foods and human biological fluids[J]. Journal of Chromatography B, 777, 93–109.
223.
WangC-C, PrasainJK, BarnesS. (2002) Review of the methods used in the determination of phytoestrogens. Journal of Chromatography B, 777, 3–28.
224.
IritiM, RossoniM, BorgoM, FerraraL, FaoroF. (2005) Induction of resistance to gray mold with benzothiadiazole modifies amino acids profile and increases proanthocyanidins in grape: primary versus secondary metabolism. Journal of Agricultural and Food Chemistry, 53, 9133–9139.
225.
HipskindJ, PaivaN. (2000) Constitutive accumulation of a resveratrol-glucoside in transgenic alfalfa increases resistance to Phoma medicaginis. Molecular Plant-Microbe Interactions, 13, 551–562.
